To evaluate the effect of topical urea in secondary prophylaxis of hand foot skin reaction in cancer patients undergoing sunitinib chemotherapy- A double blind randomized pilot study

Dr Pooja Gupta0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Patients of either gender with age >= 18 years
•2.Patients already diagnosed of cancer (Renal cell carcinoma, Gastrointestinal stromal tumour, Pancreatic neuroendocrine tumor) and were given sunitinib
•3.Patients who had hand foot skin reaction to sunitinib in the previous cycle
•4.Patient willing to avoid pregnancy during the study period
•5.Patients must have the ability to understand and be willing to sign a written informed consent document prior to registration in the study.

•1.Patient receiving concomitant medication(s) known to cause or aggravate hand foot skin reaction
•2.Patients receiving any other topical drug or investigational drug
•3.History of allergy to urea topical application any time in the past
•4.Patient with any infectious disease at present requiring pharmacotherapy (eg. Tuberculosis)
•5.Co-morbid conditions like diabetes mellitus, chronic kidney disease (except in renal cancer patient), autoimmune disease like amyloidosis
•6.Patients who have not recovered from adverse events due to agents administered earlier
•7.Pregnant or nursing females

发起方

Dr Pooja Gupta